The Dark Side of Combination Therapy: Tardive Dyskinesia in an Autistic Patient Using Fluoxetine and Dual Antipsychotics

Basit Öğe Kaydı
dc.authorscopusid58965856100
dc.authorscopusid57200174482
dc.contributor.authorGüneydaş Yıldırım B.
dc.contributor.authorAykutlu H.C.
dc.date.accessioned2024-06-12T10:26:22Z
dc.date.available2024-06-12T10:26:22Z
dc.date.issued2024
dc.description.abstractIn recent years, in addition to the use of antipsychotics, case reports of extra-pyramidal symptoms (EPS) associated with the use of selective serotonin reuptake inhibitors have been reported with increasing frequency. Tardive dyskinesia, one of the EPS, is a serious movement disorder that is difficult to treat and can lead to impaired social functioning. Occurrence during the stable course of the treatment may increase the risk of being undiagnosed in the clinic. In this study, tardive dyskinesia symptoms, differential diagnosis and treatment process developed after fluoxetine dose increase in an adolescent patient with autism who has been using fluoxetine treatment for the last 6 years in addition to dual atypical antipsychotic (risperidone and aripiprazole) treatment, which she has been using for 11 years, are shared. © 2024 Yazar. Türkiye Çocuk ve Gençlik Psikiyatrisi Derneği adına Galenos Yayınevi tarafından yayımlanmıştır.en_US
dc.identifier.doi10.4274/tjcamh.galenos.2024.92905
dc.identifier.endpage102en_US
dc.identifier.issn2687-3532
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-85189134287en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage99en_US
dc.identifier.urihttps://doi.org/10.4274/tjcamh.galenos.2024.92905
dc.identifier.urihttps://hdl.handle.net/20.500.14551/16807
dc.identifier.volume31en_US
dc.indekslendigikaynakScopusen_US
dc.language.isotren_US
dc.publisherGalenos Publishing Houseen_US
dc.relation.ispartofTurkish Journal of Child and Adolescent Mental Healthen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAntipsychotic; Autism; Child; Fluoxetine; Tardive Dyskinesiaen_US
dc.subjectAripiprazole; Fluoxetine; Neuroleptic Agent; Risperidone; Serotonin Uptake Inhibitor; Adolescent; Article; Autism; Case Report; Clinical Article; Combination Drug Therapy; Differential Diagnosis; Drug Dose Increase; Extrapyramidal Symptom; Female; Human; Social Interaction; Tardive Dyskinesiaen_US
dc.titleThe Dark Side of Combination Therapy: Tardive Dyskinesia in an Autistic Patient Using Fluoxetine and Dual Antipsychoticsen_US
dc.title.alternativeKombinasyon Tedavisinin Karanlık Yüzü: Fluoksetin ve İkili Antipsikotik Kullanan Otizmli Bir Hastada Tardif Diskinezien_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu